Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1840 1
1875 1
1878 2
1888 1
1889 2
1891 1
1896 1
1898 1
1906 1
1913 1
1915 1
1916 1
1917 1
1920 2
1922 1
1930 1
1931 1
1932 1
1935 1
1938 3
1939 1
1940 2
1941 5
1943 7
1944 2
1945 7
1946 10
1947 16
1948 16
1949 5
1950 10
1951 13
1952 10
1953 10
1954 17
1955 11
1956 8
1957 8
1958 11
1959 11
1960 11
1961 10
1962 8
1963 12
1964 14
1965 20
1966 21
1967 34
1968 31
1969 48
1970 38
1971 35
1972 33
1973 35
1974 26
1975 32
1976 42
1977 44
1978 33
1979 38
1980 43
1981 63
1982 60
1983 48
1984 47
1985 49
1986 52
1987 61
1988 69
1989 68
1990 55
1991 80
1992 74
1993 80
1994 102
1995 102
1996 83
1997 90
1998 91
1999 103
2000 132
2001 152
2002 164
2003 191
2004 173
2005 227
2006 279
2007 282
2008 290
2009 321
2010 318
2011 365
2012 406
2013 401
2014 395
2015 415
2016 465
2017 514
2018 491
2019 522
2020 584
2021 652
2022 646
2023 608
2024 527

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,531 results

Results by year

Filters applied: . Clear all
Page 1
NAFLD and cardiovascular diseases: a clinical review.
Kasper P, Martin A, Lang S, Kütting F, Goeser T, Demir M, Steffen HM. Kasper P, et al. Among authors: martin a. Clin Res Cardiol. 2021 Jul;110(7):921-937. doi: 10.1007/s00392-020-01709-7. Epub 2020 Jul 21. Clin Res Cardiol. 2021. PMID: 32696080 Free PMC article. Review.
Translocation of Viable Gut Microbiota to Mesenteric Adipose Drives Formation of Creeping Fat in Humans.
Ha CWY, Martin A, Sepich-Poore GD, Shi B, Wang Y, Gouin K, Humphrey G, Sanders K, Ratnayake Y, Chan KSL, Hendrick G, Caldera JR, Arias C, Moskowitz JE, Ho Sui SJ, Yang S, Underhill D, Brady MJ, Knott S, Kaihara K, Steinbaugh MJ, Li H, McGovern DPB, Knight R, Fleshner P, Devkota S. Ha CWY, et al. Among authors: martin a. Cell. 2020 Oct 29;183(3):666-683.e17. doi: 10.1016/j.cell.2020.09.009. Epub 2020 Sep 28. Cell. 2020. PMID: 32991841 Free PMC article.
Inspiratory Muscle Rehabilitation in Critically Ill Adults. A Systematic Review and Meta-Analysis.
Vorona S, Sabatini U, Al-Maqbali S, Bertoni M, Dres M, Bissett B, Van Haren F, Martin AD, Urrea C, Brace D, Parotto M, Herridge MS, Adhikari NKJ, Fan E, Melo LT, Reid WD, Brochard LJ, Ferguson ND, Goligher EC. Vorona S, et al. Among authors: martin ad. Ann Am Thorac Soc. 2018 Jun;15(6):735-744. doi: 10.1513/AnnalsATS.201712-961OC. Ann Am Thorac Soc. 2018. PMID: 29584447 Free PMC article.
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial.
Buteau JP, Martin AJ, Emmett L, Iravani A, Sandhu S, Joshua AM, Francis RJ, Zhang AY, Scott AM, Lee ST, Azad AA, McJannett MM, Stockler MR, Williams SG, Davis ID, Hofman MS; TheraP Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Buteau JP, et al. Among authors: martin aj. Lancet Oncol. 2022 Nov;23(11):1389-1397. doi: 10.1016/S1470-2045(22)00605-2. Epub 2022 Oct 16. Lancet Oncol. 2022. PMID: 36261050 Clinical Trial.
Elucidation of the pathway for biosynthesis of saponin adjuvants from the soapbark tree.
Reed J, Orme A, El-Demerdash A, Owen C, Martin LBB, Misra RC, Kikuchi S, Rejzek M, Martin AC, Harkess A, Leebens-Mack J, Louveau T, Stephenson MJ, Osbourn A. Reed J, et al. Among authors: martin ac. Science. 2023 Mar 24;379(6638):1252-1264. doi: 10.1126/science.adf3727. Epub 2023 Mar 23. Science. 2023. PMID: 36952412 Free article.
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.
Tree AC, Ostler P, van der Voet H, Chu W, Loblaw A, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Armstrong J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Duffton A, Brand DH, Henderson D, Morrison K, Brown S, Pugh J, Burnett S, Mahmud M, Hinder V, Naismith O, Hall E, van As N; PACE Trial Investigators. Tree AC, et al. Among authors: martin a. Lancet Oncol. 2022 Oct;23(10):1308-1320. doi: 10.1016/S1470-2045(22)00517-4. Epub 2022 Sep 13. Lancet Oncol. 2022. PMID: 36113498 Free article. Clinical Trial.
Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.
O'Malley DM, Matulonis UA, Birrer MJ, Castro CM, Gilbert L, Vergote I, Martin LP, Mantia-Smaldone GM, Martin AG, Bratos R, Penson RT, Malek K, Moore KN. O'Malley DM, et al. Among authors: martin ag. Gynecol Oncol. 2020 May;157(2):379-385. doi: 10.1016/j.ygyno.2020.01.037. Epub 2020 Feb 18. Gynecol Oncol. 2020. PMID: 32081463 Clinical Trial.
10,531 results
You have reached the last available page of results. Please see the User Guide for more information.